Annual FCF
-$44.91 M
-$1.46 M-3.35%
December 31, 2023
Summary
- As of February 18, 2025, GRTX annual free cash flow is -$44.91 million, with the most recent change of -$1.46 million (-3.35%) on December 31, 2023.
- During the last 3 years, GRTX annual FCF has risen by +$15.09 million (+25.15%).
- GRTX annual FCF is now -99.47% below its all-time high of -$22.51 million, reached on December 31, 2018.
Performance
GRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.30 M
+$419.00 K+15.42%
September 1, 2024
Summary
- As of February 18, 2025, GRTX quarterly free cash flow is -$2.30 million, with the most recent change of +$419.00 thousand (+15.42%) on September 1, 2024.
- Over the past year, GRTX quarterly FCF has increased by +$7.63 million (+76.84%).
- GRTX quarterly FCF is now at all-time high.
Performance
GRTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$19.73 M
+$10.22 M+34.13%
September 1, 2024
Summary
- As of February 18, 2025, GRTX TTM free cash flow is -$19.73 million, with the most recent change of +$10.22 million (+34.13%) on September 1, 2024.
- Over the past year, GRTX TTM FCF has increased by +$25.18 million (+56.06%).
- GRTX TTM FCF is now -113.71% below its all-time high of -$9.23 million, reached on March 31, 2019.
Performance
GRTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
GRTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.4% | +76.8% | +56.1% |
| 3 y3 years | +25.1% | +76.8% | +56.1% |
| 5 y5 years | -99.5% | +76.8% | +56.1% |
GRTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.4% | +34.2% | at high | +86.9% | at high | +71.1% |
| 5 y | 5-year | -3.4% | +34.2% | at high | +87.5% | at high | +71.1% |
| alltime | all time | -99.5% | +34.2% | at high | +87.5% | -113.7% | +71.1% |
Galera Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.30 M(-15.4%) | -$19.73 M(-34.1%) |
| Jun 2024 | - | -$2.72 M(-43.3%) | -$29.95 M(-21.2%) |
| Mar 2024 | - | -$4.79 M(-51.7%) | -$38.03 M(-15.3%) |
| Dec 2023 | -$44.91 M(+3.4%) | -$9.92 M(-20.7%) | -$44.91 M(-8.2%) |
| Sep 2023 | - | -$12.52 M(+16.0%) | -$48.93 M(+7.2%) |
| Jun 2023 | - | -$10.80 M(-7.5%) | -$45.62 M(+4.4%) |
| Mar 2023 | - | -$11.67 M(-16.3%) | -$43.72 M(+0.6%) |
| Dec 2022 | -$43.45 M(-36.3%) | -$13.95 M(+51.3%) | -$43.45 M(-7.6%) |
| Sep 2022 | - | -$9.21 M(+3.6%) | -$47.01 M(-16.4%) |
| Jun 2022 | - | -$8.89 M(-22.0%) | -$56.22 M(-12.4%) |
| Mar 2022 | - | -$11.40 M(-34.9%) | -$64.15 M(-6.0%) |
| Dec 2021 | -$68.24 M | -$17.50 M(-5.0%) | -$68.24 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$18.43 M(+9.5%) | -$67.24 M(+4.9%) |
| Jun 2021 | - | -$16.82 M(+8.6%) | -$64.10 M(+1.7%) |
| Mar 2021 | - | -$15.49 M(-6.1%) | -$63.05 M(+5.1%) |
| Dec 2020 | -$59.99 M(+26.9%) | -$16.50 M(+7.9%) | -$59.99 M(+2.0%) |
| Sep 2020 | - | -$15.29 M(-3.1%) | -$58.84 M(+4.1%) |
| Jun 2020 | - | -$15.78 M(+26.9%) | -$56.51 M(+11.9%) |
| Mar 2020 | - | -$12.43 M(-19.0%) | -$50.49 M(+6.8%) |
| Dec 2019 | -$47.29 M(+110.1%) | -$15.34 M(+18.4%) | -$47.29 M(+48.0%) |
| Sep 2019 | - | -$12.96 M(+32.8%) | -$31.95 M(+68.2%) |
| Jun 2019 | - | -$9.76 M(+5.7%) | -$18.99 M(+105.7%) |
| Mar 2019 | - | -$9.23 M | -$9.23 M |
| Dec 2018 | -$22.51 M(-5.1%) | - | - |
| Dec 2017 | -$23.73 M | - | - |
FAQ
- What is Galera Therapeutics annual free cash flow?
- What is the all time high annual FCF for Galera Therapeutics?
- What is Galera Therapeutics annual FCF year-on-year change?
- What is Galera Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Galera Therapeutics?
- What is Galera Therapeutics quarterly FCF year-on-year change?
- What is Galera Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Galera Therapeutics?
- What is Galera Therapeutics TTM FCF year-on-year change?
What is Galera Therapeutics annual free cash flow?
The current annual FCF of GRTX is -$44.91 M
What is the all time high annual FCF for Galera Therapeutics?
Galera Therapeutics all-time high annual free cash flow is -$22.51 M
What is Galera Therapeutics annual FCF year-on-year change?
Over the past year, GRTX annual free cash flow has changed by -$1.46 M (-3.35%)
What is Galera Therapeutics quarterly free cash flow?
The current quarterly FCF of GRTX is -$2.30 M
What is the all time high quarterly FCF for Galera Therapeutics?
Galera Therapeutics all-time high quarterly free cash flow is -$2.30 M
What is Galera Therapeutics quarterly FCF year-on-year change?
Over the past year, GRTX quarterly free cash flow has changed by +$7.63 M (+76.84%)
What is Galera Therapeutics TTM free cash flow?
The current TTM FCF of GRTX is -$19.73 M
What is the all time high TTM FCF for Galera Therapeutics?
Galera Therapeutics all-time high TTM free cash flow is -$9.23 M
What is Galera Therapeutics TTM FCF year-on-year change?
Over the past year, GRTX TTM free cash flow has changed by +$25.18 M (+56.06%)